3,4-dihydroxyphenylacetic acid has been researched along with harmaline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blyden, GT; Brown, JW; Okonmah, AD; Soliman, KF | 1 |
| Fuller, RW; Hemrick-Luecke, SK | 1 |
| Berghauzen, K; Kolasiewicz, W; Kuter, K; Nowak, P; Ossowska, K; Schulze, G | 1 |
3 other study(ies) available for 3,4-dihydroxyphenylacetic acid and harmaline
| Article | Year |
|---|---|
Prenatal effects of acute harmaline exposure on fetal brain biogenic amine metabolism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alkaloids; Animals; Biogenic Amines; Brain Chemistry; Catechol O-Methyltransferase; Chromatography, High Pressure Liquid; Dopamine; Female; Harmaline; Homovanillic Acid; Hydroxyindoleacetic Acid; Mice; Norepinephrine; Pregnancy; Rats; Rats, Inbred Strains; Time Factors | 1988 |
Influence of selective, reversible inhibitors of monoamine oxidase on the prolonged depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Alkaloids; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Harmaline; Homovanillic Acid; Male; Mice; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Oxidation-Reduction; Pyridines | 1985 |
6-OHDA injections into A8-A9 dopaminergic neurons modelling early stages of Parkinson's disease increase the harmaline-induced tremor in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Animals; Central Nervous System Stimulants; Cerebellum; Chromatography, High Pressure Liquid; Dopaminergic Neurons; Harmaline; Hydroxyindoleacetic Acid; Male; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; Serotonin; Statistics, Nonparametric; Substantia Nigra; Tremor; Tyrosine 3-Monooxygenase | 2012 |